7.80
price down icon2.86%   -0.23
pre-market  Pre-market:  7.60   -0.20   -2.56%
loading

Candel Therapeutics Inc Stock (CADL) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - 0.102
Operating Expenses
23.42%
7.902
10.32 8.861 9.579 9.633
Interest Income/Expense
4.01%
0.646
0.673 0.669 0.644 0.609
Operating Income/Loss
23.42%
-7.902
-10.32 -8.861 -9.579 -9.633
Nonoperating Income/Loss
58.94%
-0.319
-0.777 0.426 -0.035 0.838
Income/Loss From Continuing Operations Before Tax
25.90%
-8.221
-11.10 -8.435 -9.614 -8.795
Income/Loss From Continuing Operations After Tax
25.90%
-8.221
-11.10 -8.435 -9.614 -8.795
Net Income/Loss
25.90%
-8.221
-11.10 -8.435 -9.614 -8.795
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
188.53K%
29.20
0.0155 28.92 28.92 28.92
Diluted Average Shares
188.53K%
29.20
0.0155 28.92 28.92 28.92
Basic Earnings Per Share
26.32%
-0.28
-0.38 -0.29 -0.33 -0.30
Diluted Earnings Per Share
26.32%
-0.28
-0.38 -0.29 -0.33 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):